Biotechnology: a key ally in the fight against breast cancer 19/10/2025 Healthcare Access to innovation According to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected... AseBio - InnoUp Farma
Biotechnology: a key ally in the fight against breast cancer 19/10/2025 InnoUp Farma Biotechnological innovation is transforming treatments toward safer, more effective and personalized options... AseBio - InnoUp Farma
#NewAseBioMember | “It is much more than an industry association; it is the meeting point ... 13/10/2025 Healthcare Corporate Meet Fundación para la Investigación de Sanitas Hospitales, our new member. We spoke with José Francisco Tomás... Partners - Fundación para la Investigación y la Innovación Médica de Sanitas Hospitales
Dan*na starts industrial production of its bioplastic, PLH, under worldwide patent with po... 02/10/2025 Healthcare The start-up Dan*na (Artificial Nature S.L.), based at the Barcelona Science Park, has validated the industrial scale-up... Partners - Parc Científic de Barcelona
The first Natac Awards achieve remarkable engagement 30/09/2025 Healthcare Communication La primera edición de los Premios Natac cierra con gran participación, destacando el talento del personal investigador... Partners - Natac Group
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Fundación Científica de la Asociación Española Contra el Cáncer Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Rafael Navajo: "The participation of VHIR in the structure of companies derived from its r... 23/09/2025 Healthcare Corporate Rafael Navajo - Director of the Innovation and Business Development Area at VHIR (Vall d'Hebron Research Institute) Partners - GENESIS Biomed
ORYZON to sponsor first Phelan-McDermid syndrome (PMS) burden of illness study 23/09/2025 Healthcare Access to innovation Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system Partners - Oryzon Genomics
Global innovation for the objective control of fish freshness 18/09/2025 Healthcare Agrifood Biolan launches a disruptive, unique, digitized and sustainable technological solution to the fishing industry: biofish... Partners - Biolan
